Kerry Whalen

Kerry Whalen has over twenty years of work experience in the biotechnology and pharmaceutical industries. Kerry began their career in 1998 as a Graduate Student at Tufts University. In 2005, they joined Pfizer as a Post Doctoral associate. In 2008, they moved to AVEO Oncology as a Senior Scientist. From 2013 to 2020, they held various roles at Tarveda Therapeutics, including Senior Director of Discovery and Translational Biology, Director of Discovery and Translational Biology, and Senior Scientist. In 2020, they joined Cullinan Oncology as Senior Director of Preclinical and Early Development- Biologic.

Kerry Whalen obtained a B.S. in Microbiology from the University of Massachusetts Amherst between 1994 and 1998. Kerry then went on to obtain a PhD in Genetics from Tufts University School of Medicine between 1998 and 2005.